Please login (Members) to view content or
(Nonmembers) this article.
0
No votes yet

Cardiovascular Risk in Testicular Cancer Survivors Treated With Chemotherapy: Incidence, Significance, and Practice Implications

Barbara H. Zoltick
Linda A. Jacobs
David J. Vaughn
ONF 2005, 32(5), 1005-1012 DOI: 10.1188/05.ONF.1005-1012

Purpose/Objectives: To explore what is known regarding cardiovascular late effects of treatment, such as Raynaud phenomenon, hypertension, hyperlipidemia, and coronary artery disease as well as the risk for cardiovascular events experienced by patients with testicular cancer treated with chemotherapy.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or